Duopharma Biotech Berhad (KLSE:DPHARMA)
1.380
+0.010 (0.73%)
At close: Sep 12, 2025
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.33 billion as of September 12, 2025. Its market cap has increased by 12.20% in one year.
Market Cap
1.33B
Enterprise Value
1.57B
Revenue
886.92M
Ranking
n/a
PE Ratio
17.34
Stock Price
1.38
Market Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.33B, an increase of 609.89%. That is a compound annual growth rate of 8.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 1.33B | 10.40% |
Dec 31, 2024 | 1.20B | -0.79% |
Dec 29, 2023 | 1.21B | -20.94% |
Dec 30, 2022 | 1.53B | -3.10% |
Dec 31, 2021 | 1.58B | -33.70% |
Dec 31, 2020 | 2.39B | 145.56% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Malayan Banking Berhad | 120.45B |
Public Bank Berhad | 83.05B |
CIMB Group Holdings Berhad | 77.58B |
Tenaga Nasional Berhad | 76.83B |
IHH Healthcare Berhad | 62.75B |
Press Metal Aluminium Holdings Berhad | 46.31B |
Celcomdigi Berhad | 43.41B |
Hong Leong Bank Berhad | 41.29B |